1. Home
  2. COEP vs VBIX Comparison

COEP vs VBIX Comparison

Compare COEP & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • VBIX
  • Stock Information
  • Founded
  • COEP 2017
  • VBIX N/A
  • Country
  • COEP United States
  • VBIX Israel
  • Employees
  • COEP N/A
  • VBIX N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • VBIX Computer Software: Prepackaged Software
  • Sector
  • COEP Health Care
  • VBIX Technology
  • Exchange
  • COEP Nasdaq
  • VBIX Nasdaq
  • Market Cap
  • COEP 27.4M
  • VBIX 26.4M
  • IPO Year
  • COEP N/A
  • VBIX N/A
  • Fundamental
  • Price
  • COEP $9.81
  • VBIX $5.42
  • Analyst Decision
  • COEP
  • VBIX
  • Analyst Count
  • COEP 0
  • VBIX 0
  • Target Price
  • COEP N/A
  • VBIX N/A
  • AVG Volume (30 Days)
  • COEP 37.8K
  • VBIX 184.4K
  • Earning Date
  • COEP 08-15-2025
  • VBIX 08-14-2025
  • Dividend Yield
  • COEP N/A
  • VBIX N/A
  • EPS Growth
  • COEP N/A
  • VBIX N/A
  • EPS
  • COEP N/A
  • VBIX N/A
  • Revenue
  • COEP $62,874.00
  • VBIX $19,672,000.00
  • Revenue This Year
  • COEP N/A
  • VBIX N/A
  • Revenue Next Year
  • COEP N/A
  • VBIX N/A
  • P/E Ratio
  • COEP N/A
  • VBIX N/A
  • Revenue Growth
  • COEP N/A
  • VBIX N/A
  • 52 Week Low
  • COEP $2.31
  • VBIX $0.18
  • 52 Week High
  • COEP $13.70
  • VBIX $12.00
  • Technical
  • Relative Strength Index (RSI)
  • COEP 65.80
  • VBIX N/A
  • Support Level
  • COEP $7.25
  • VBIX N/A
  • Resistance Level
  • COEP $9.90
  • VBIX N/A
  • Average True Range (ATR)
  • COEP 0.57
  • VBIX 0.00
  • MACD
  • COEP 0.30
  • VBIX 0.00
  • Stochastic Oscillator
  • COEP 100.00
  • VBIX 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

Share on Social Networks: